{"id":28103,"date":"2024-11-04T11:47:34","date_gmt":"2024-11-04T10:47:34","guid":{"rendered":"https:\/\/ggba.swiss\/?p=28103"},"modified":"2024-11-04T11:47:35","modified_gmt":"2024-11-04T10:47:35","slug":"alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/","title":{"rendered":"AlveoliX achieves breakthrough with Lung-on-Chip model in respiratory research"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.alveolix.com\/\">AlveoliX<\/a>, known for its award-winning Lung-on-Chip technology, has reached a new milestone with the publication of a study in Bioengineering &amp; Translational Medicine. Conducted in collaboration with <a href=\"https:\/\/www.vitrocell.com\/\">Vitrocell Systems<\/a>, the <a href=\"https:\/\/www.unibe.ch\/index_eng.html\">University of Bern<\/a> and the Helmholtz Institute for Pharmaceutical Research Saarland (<a href=\"https:\/\/www.helmholtz-hips.de\/en\/\">HIPS<\/a>), the study validates the potential of AlveoliX&#8217;s Lung-on-Chip model as a precise tool for studying respiratory diseases and testing treatments.<\/p>\n\n\n\n<p>The study, titled &#8220;A stretchable human lung-on-chip model of alveolar inflammation for evaluating anti-inflammatory drug response,&#8221; demonstrates how AlveoliX&#8217;s Lung-on-Chip technology mimics the microenvironment of the human alveoli, closely simulating both respiratory dynamics and inflammatory disease conditions. This innovative model supports the study of complex respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis and acute respiratory distress syndrome (ARDS), and provides a more predictive approach to drug screening and toxicity testing.<\/p>\n\n\n\n<p>The Lung-on-Chip system uses patient-derived cells, allowing researchers to evaluate personalized treatment responses and bridge the gap between preclinical and clinical research. The AlveoliX model also reduces the need for animal testing, in line with the 3Rs (Replace, Reduce, Refine) principle for more ethical and accurate research methods.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Pushing the boundaries of preclinical testing<\/h4>\n\n\n\n<p>The success of the study highlights the strength of AlveoliX&#8217;s collaborative approach, supported by the <a href=\"https:\/\/www.innosuisse.admin.ch\/en\/eurostars-projects\">Eurostars<\/a> AIM-4-Doc grant. Bringing together industry partners AlveoliX and Vitrocell Systems with academic expertise from the University of Bern and HIPS, the collaboration is advancing the application of organ-on-chip technology in drug development, inhalation exposure testing and broader toxicological assessments.<\/p>\n\n\n\n<p>AlveoliX, <a href=\"https:\/\/ggba.swiss\/en\/bernese-start-up-alveolix-wins-the-swiss-medtech-award-2022\/\">a previous recipient of the Swiss Medtech Award for its Lung-on-Chip innovation<\/a>, continues to push the boundaries in preclinical testing. The company\u2019s work aims to establish a new standard in respiratory research, with potential applications extending to environmental studies and safety evaluations for chemicals, pesticides, and cosmetics.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bernese start-up AlveoliX has published a study confirming the efficacy of its Lung-on-Chip model the study of respiratory diseases. The study, conducted with leading academic and industrial partners, demonstrates the model&#8217;s potential for personalized and ethical testing.<\/p>\n","protected":false},"author":6,"featured_media":28104,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[890,963,926,902],"class_list":["post-28103","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-healthcare","tag-medical-devices","tag-medtech","tag-personalized-medicine"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AlveoliX achieves breakthrough with its Lung-on-Chip model<\/title>\n<meta name=\"description\" content=\"Bernese start-up AlveoliX has published a study confirming the efficacy of its Lung-on-Chip model the study of respiratory diseases.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AlveoliX achieves breakthrough with its Lung-on-Chip model\" \/>\n<meta property=\"og:description\" content=\"Bernese start-up AlveoliX has published a study confirming the efficacy of its Lung-on-Chip model the study of respiratory diseases.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-04T10:47:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-04T10:47:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Alveolix-Lung-on-Chip-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"AlveoliX achieves breakthrough with Lung-on-Chip model in respiratory research\",\"datePublished\":\"2024-11-04T10:47:34+00:00\",\"dateModified\":\"2024-11-04T10:47:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/\"},\"wordCount\":307,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Alveolix-Lung-on-Chip-1180x811-1.jpg\",\"keywords\":[\"Healthcare\",\"Medical Devices\",\"Medtech\",\"Personalized Medicine\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/\",\"url\":\"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/\",\"name\":\"AlveoliX achieves breakthrough with its Lung-on-Chip model\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Alveolix-Lung-on-Chip-1180x811-1.jpg\",\"datePublished\":\"2024-11-04T10:47:34+00:00\",\"dateModified\":\"2024-11-04T10:47:35+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Bernese start-up AlveoliX has published a study confirming the efficacy of its Lung-on-Chip model the study of respiratory diseases.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Alveolix-Lung-on-Chip-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Alveolix-Lung-on-Chip-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"AlveoliX\u2019s Lung-on-Chip technology mimics human lung conditions to improve research accuracy in respiratory diseases, enhancing drug testing while reducing reliance on animal models. | \u00a9 AlveoliX\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AlveoliX achieves breakthrough with Lung-on-Chip model in respiratory research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AlveoliX achieves breakthrough with its Lung-on-Chip model","description":"Bernese start-up AlveoliX has published a study confirming the efficacy of its Lung-on-Chip model the study of respiratory diseases.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/","og_locale":"en_US","og_type":"article","og_title":"AlveoliX achieves breakthrough with its Lung-on-Chip model","og_description":"Bernese start-up AlveoliX has published a study confirming the efficacy of its Lung-on-Chip model the study of respiratory diseases.","og_url":"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-11-04T10:47:34+00:00","article_modified_time":"2024-11-04T10:47:35+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Alveolix-Lung-on-Chip-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"AlveoliX achieves breakthrough with Lung-on-Chip model in respiratory research","datePublished":"2024-11-04T10:47:34+00:00","dateModified":"2024-11-04T10:47:35+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/"},"wordCount":307,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Alveolix-Lung-on-Chip-1180x811-1.jpg","keywords":["Healthcare","Medical Devices","Medtech","Personalized Medicine"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/","url":"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/","name":"AlveoliX achieves breakthrough with its Lung-on-Chip model","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Alveolix-Lung-on-Chip-1180x811-1.jpg","datePublished":"2024-11-04T10:47:34+00:00","dateModified":"2024-11-04T10:47:35+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Bernese start-up AlveoliX has published a study confirming the efficacy of its Lung-on-Chip model the study of respiratory diseases.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Alveolix-Lung-on-Chip-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Alveolix-Lung-on-Chip-1180x811-1.jpg","width":1180,"height":811,"caption":"AlveoliX\u2019s Lung-on-Chip technology mimics human lung conditions to improve research accuracy in respiratory diseases, enhancing drug testing while reducing reliance on animal models. | \u00a9 AlveoliX"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/alveolix-achieves-breakthrough-with-lung-on-chip-model-in-respiratory-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"AlveoliX achieves breakthrough with Lung-on-Chip model in respiratory research"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/28103","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=28103"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/28103\/revisions"}],"predecessor-version":[{"id":28107,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/28103\/revisions\/28107"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/28104"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=28103"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=28103"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=28103"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}